{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:10:56Z","timestamp":1788930656150,"version":"build-2803163510"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:title>Graphical Abstract<\/jats:title><jats:p><jats:fig><jats:caption><jats:p>Created with <jats:ext-link>Biorender.com<\/jats:ext-link>.<\/jats:p><\/jats:caption><\/jats:fig><\/jats:p>","DOI":"10.3389\/fphar.2024.1403147","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T07:53:15Z","timestamp":1726041195000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Cannabidiol, a plant-derived compound, is an emerging strategy for treating cognitive impairments: comprehensive review of randomized trials"],"prefix":"10.3389","volume":"15","author":[{"given":"Adriana","family":"Yndart Arias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Vadell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arti","family":"Vashist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagesh","family":"Kolishetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madepalli K.","family":"Lakshmana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhavan","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan P.","family":"Liuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"B1","unstructured":"Anxiety disorders - facts and statistics2024"},{"key":"B2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jad.2022.04.130","article-title":"Social anxiety and behavioral assessments of social cognition: a systematic review","volume":"311","author":"Alvi","year":"2022","journal-title":"J. Affect. Disord."},{"key":"B3","volume-title":"Evidence analysis manual","year":"2022"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1001\/jama.2020.21218","article-title":"Effect of cannabidiol and \u03949-tetrahydrocannabinol on driving performance: a randomized clinical trial","volume":"324","author":"Arkell","year":"2020","journal-title":"Jama"},{"key":"B5","doi-asserted-by":"publisher","first-page":"105670","DOI":"10.1016\/j.nbd.2022.105670","article-title":"Synaptic changes induced by cannabinoid drugs and cannabis use disorder","volume":"167","author":"Augustin","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"R608","DOI":"10.1016\/j.cub.2019.05.044","article-title":"What is cognition?","volume":"29","author":"Bayne","year":"2019","journal-title":"Curr. Biol. CB"},{"key":"B7","doi-asserted-by":"publisher","first-page":"21m14130","DOI":"10.4088\/JCP.21m14130","article-title":"Cannabidiol for treatment-Resistant anxiety disorders in young People: an open-Label trial","volume":"83","author":"Berger","year":"2022","journal-title":"J. Clin. psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"989717","DOI":"10.3389\/fphar.2022.989717","article-title":"Cannabidiol for neurodegenerative disorders: a comprehensive review","volume":"13","author":"Bhunia","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1111\/epi.16093","article-title":"Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy","volume":"60","author":"Birnbaum","year":"2019","journal-title":"Epilepsia"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00213-022-06070-3","article-title":"The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study","volume":"239","author":"Bloomfield","year":"2022","journal-title":"Psychopharmacology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00213-018-4885-9","article-title":"The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial","volume":"235","author":"Boggs","year":"2018","journal-title":"Psychopharmacology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00213-021-06043-y","article-title":"Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder","volume":"239","author":"Bolsoni","year":"","journal-title":"Psychopharmacology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1590\/1516-4446-2021-2317","article-title":"The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event","volume":"44","author":"Bolsoni","year":"","journal-title":"Rev. Bras. Psiquiatr. Sao Paulo, Braz."},{"key":"B14","unstructured":"Source: division of population health, N. C. F. C. D. P. A. H. P. Subjective cognitive decline \u2014 a public health issue2024"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7812\/TPP\/19.200","article-title":"Mechanisms of action and pharmacokinetics of cannabis","volume":"25","author":"Chayasirisobhon","year":"2020","journal-title":"Perm. J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.3390\/cells12232672","article-title":"Assessing cannabidiol as a therapeutic agent for preventing and alleviating Alzheimer's disease neurodegeneration","volume":"12","author":"Chen","year":"2023","journal-title":"Cells"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.3390\/nu15122664","article-title":"Effects of oral cannabidiol on health and fitness in healthy adults: an 8-week randomized trial","volume":"15","author":"Flores","year":"2023","journal-title":"Nutrients"},{"key":"B18","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.euroneuro.2018.04.004","article-title":"Probing the endocannabinoid system in healthy volunteers: cannabidiol alters fronto-striatal resting-state connectivity","volume":"28","author":"Grimm","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants","volume":"95","author":"Hampson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1038\/npp.2015.367","article-title":"Oral cannabidiol does not alter the subjective, reinforcing or cardiovascular effects of smoked cannabis","volume":"41","author":"Haney","year":"2016","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.biopsych.2011.12.027","article-title":"Anxiety and decision-making","volume":"72","author":"Hartley","year":"2012","journal-title":"Biol. psychiatry"},{"key":"B22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1176\/appi.ajp.2019.18101191","article-title":"Cannabidiol for the reduction of cue-induced craving and anxiety in drug-Abstinent individuals with heroin Use disorder: a double-blind randomized placebo-controlled trial","volume":"176","author":"Hurd","year":"2019","journal-title":"Am. J. psychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"147586","DOI":"10.1016\/j.brainres.2021.147586","article-title":"Effects of cannabinoid (CBD) on blood brain barrier permeability after brain injury in rats","volume":"1768","author":"Jiang","year":"2021","journal-title":"Brain Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"9582","DOI":"10.3390\/ijms22179582","article-title":"Pharmacokinetic drug-drug Interactions among Antiepileptic drugs, including CBD, drugs used to treat COVID-19 and Nutrients","volume":"22","author":"Kara\u017aniewicz-\u0141ada","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B25","article-title":"Medication routes of administration","volume-title":"StatPearls","author":"Kim","year":"2023"},{"key":"B26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.euroneuro.2023.04.001","article-title":"Anxiolytic effects of endocannabinoid enhancing compounds: a systematic review and meta-analysis","volume":"72","author":"Kwee","year":"2023","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00213-022-06303-5","article-title":"Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder","volume":"240","author":"Lees","year":"2023","journal-title":"Psychopharmacology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5980","DOI":"10.3390\/molecules28165980","article-title":"Molecular and Cellular mechanisms of action of cannabidiol","volume":"28","author":"Martinez Naya","year":"2023","journal-title":"Mol. Basel, Switz."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1177\/02698811221095356","article-title":"Effects of cannabidiol on simulated driving and cognitive performance: a dose-ranging randomised controlled trial","volume":"36","author":"McCartney","year":"2022","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"key":"B30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","article-title":"Cannabidiol (CBD) as an Adjunctive Therapy in schizophrenia: a Multicenter randomized controlled trial","volume":"175","author":"McGuire","year":"2018","journal-title":"Am. J. psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","article-title":"Cannabidiol: an overview of some pharmacological aspects","volume":"42","author":"Mechoulam","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/iej.13434","article-title":"Glossary for randomized clinical trials","volume":"54","author":"Nagendrababu","year":"2021","journal-title":"Int. Endod. J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4137\/SART.S25081","article-title":"Cannabidiol as an intervention for addictive behaviors: a systematic review of the evidence","volume":"9","author":"Prud'homme","year":"2015","journal-title":"Subst. abuse Res. Treat."},{"key":"B34","doi-asserted-by":"publisher","first-page":"173376","DOI":"10.1016\/j.pbb.2022.173376","article-title":"Cannabidiol effects on cognition in individuals with cocaine use disorder: exploratory results from a randomized controlled trial","volume":"216","author":"Rizkallah","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/npp.2010.171","article-title":"Cognition: the ultimate brain function","volume":"36","author":"Robbins","year":"2011","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1007\/s12035-018-1143-4","article-title":"Cannabidiol induces rapid and sustained antidepressant-like effects through increased BDNF signaling and synaptogenesis in the prefrontal cortex","volume":"56","author":"Sales","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.yebeh.2018.07.027","article-title":"Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: a randomized, double-blind, controlled trial","volume":"88","author":"Schoedel","year":"2018","journal-title":"Epilepsy and Behav. E&B"},{"key":"B38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neuroscience.2022.06.036","article-title":"Cannabidiol alleviates the damage to Dopaminergic Neurons in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-induced Parkinson's disease mice via Regulating neuronal Apoptosis and neuroinflammation","volume":"498","author":"Wang","year":"2022","journal-title":"Neuroscience"},{"key":"B39","doi-asserted-by":"publisher","first-page":"7376","DOI":"10.1038\/s41598-023-32927-4","article-title":"Anti-inflammatory effects of CBD in human microglial cell line infected with HIV-1","volume":"13","author":"Yndart Arias","year":"2023","journal-title":"Sci. Rep."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1403147\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T07:53:21Z","timestamp":1726041201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1403147\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":39,"alternative-id":["10.3389\/fphar.2024.1403147"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1403147","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"article-number":"1403147"}}